BRIEF published on 11/27/2025 at 00:20, 21 days 18 hours ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/27/2025 at 00:15, 21 days 18 hours ago Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets Transgene resumes trading of shares on Euronext Paris following capital increase results publication Euronext Paris Shares Trading Capital Increase Transgene
BRIEF published on 11/26/2025 at 23:37, 21 days 18 hours ago Transgene Raises €105 Million for Cancer Vaccine Development Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE published on 11/26/2025 at 23:32, 21 days 18 hours ago Transgene Successfully Completes a Fundraising of c. €105 Million Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028 Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF published on 11/25/2025 at 22:06, 22 days 20 hours ago Transgene raises funds with the Talisman project Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF published on 11/25/2025 at 21:47, 22 days 20 hours ago Temporary suspension of trading in Transgene shares Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/25/2025 at 21:42, 22 days 20 hours ago Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results. Trading to resume on November 27, 2025 Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 20:46, 22 days 21 hours ago Temporary Suspension of Trading in Transgene Shares on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Trading Suspended
PRESS RELEASE published on 11/25/2025 at 20:41, 22 days 21 hours ago Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 19:20, 22 days 23 hours ago Transgene Launches €105 Million Fundraising Initiative Biotechnology Investment Transgene Fundraising Myvac® Program Cancer Vaccine Development Institutional And Retail Offerings
Published on 12/18/2025 at 15:00, 3 hours 29 minutes ago Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 3 hours 58 minutes ago Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 29 minutes ago Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 29 minutes ago LQR House Announces $6.52 Million Registered Direct Offering
Published on 12/18/2025 at 18:00, 29 minutes ago Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 44 minutes ago ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 49 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 49 minutes ago VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Published on 12/18/2025 at 16:31, 1 hour 58 minutes ago In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 50 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 18:00, 1 day ago Outstanding Shares and Voting Rights Statement at 30 November 2025
